急性心肌梗死后微循环障碍的非药物治疗研究进展  

Non-drug Treatment of Coronary Microvascular Dysfunction after Acute Myocardial Infarction

作　　者：谭焜月 刘春霞[1] 熊峰[1] TAN Kunyue;LIU Chunxia;XIONG Feng(Chengdu Cardiovascular Diseases Research Institute,The Third People s Hospital of Chengdu,Chengdu 610031,Sichuan,China)

机构地区：[1]成都市第三人民医院成都市心血管病研究所

出　　处：《心血管病学进展》2019年第8期1104-1107,共4页Advances in Cardiovascular Diseases

摘　　要：经皮冠脉介入术是急性心肌梗死的重要治疗手段,但常规冠状动脉介入治疗仅能处理大血管病变,术后易发生微循环障碍(CMD)。药物治疗虽能一定程度上改善CMD,但疗效有限。随着近年来有创及无创技术的发展,心肌梗死后CMD的治疗有了新的进展。现综述心肌梗死后CMD的非药物治疗研究进展,以期探索最佳治疗策略。Percutaneous coronary intervention is an important treatment for acute myocardial infarction,but it can only treat macroangiopathy.Coronary microangiopathy also play an important role on acute myocardial infarction.Drugs can improve coronary microcirculation dysfunction(CMD)to some extent,but the effect is limited.Along with the developments of recent non-invasive and invasive techniques,treatment of CMD keeps going deeper.This paper reviews the treatment progress of CMD,and hopes to explore the best treatment strategy.

关 键 词：急性心肌梗死 冠状动脉微循环障碍 经皮冠脉介入术 

分 类 号：R54[医药卫生—心血管疾病]